The Department of Urology's Clinical Trials Office has been actively involved in a number of national and university-based trials that allow our patients access to cutting-edge medications, techniques, and diagnostic modalities.  Clinical trials are available for many different disease processes.  Our experienced staff can quickly determine by phone whether or not you may qualify for a certain trial.

Listed below are several of the current trials that are open for enrollment. If you are interested in finding out whether or not you qualify for participation in one of these trials, please contact Pamela Steele, RN, BSN,  CCRC at (615) 343-2120 or

Active Clinical Trials for Urology


  • Rapamycin Study:  A Combined Phase 1 and Phase 2 Study of Albumin-bound Rapamycin Nanoparticles (nab-rapamycin, ABI-009) in the Treatment of BCG Refractory or Recurrent Nonmuscle Invasive Transitional Cell Bladder Cancer
  • Genomic Health:  Genomic Markers in Transitional Cell Cancer of the Bladder, Renal Pelvis and Ureter:  Sample Acquisition for Methods Development and Discovery.
  • Nutrition RC Pilot Study:  A Pilot Study of Perioperative Oral Nutrition Supplementation to Improve Nutritional Status and Clinical Outcomes in Patients Undergoing Radical Cystectomy.


  • PROSPER:  A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer.


  • Cook Myosite SUI:  A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontinence